We have investigated the therapeutic effects of human peripheral blood CD34-positive cells on a rat cirrhosis model and found these cells inhibited liver fibrosis, promoted liver regeneration, improved portal hypertension, and improved prognosis by promoting intrahepatic angiogenesis and supplying various growth factors produced by EPCs to the surrounding tissues [136,137]. Here, CD34 is linked to Hepatic fibrosis.